Therapeutic Pipeline Program

the Therapeutic Pipeline Program supports Parkinson's disease therapeutic development along the pre-clinical and clinical path (both drug and non-pharmacological therapeutics, including gene therapy, biological, surgical and non-invasive approaches). Application should be relevant to: 

• Protection or restoration of degenerating and/or dysfunctional neurons affected in Parkinson’s
• Alleviation of disabling motor or non-motor symptoms of Parkinson’s not well managed by current treatments
• Reduction of complications and side effects of current Parkinson’s treatments.

Funding: $500,000 (for pre clinical research) 

Duration: 2 years 

Research Authority due date: 17.9.19

Pre proposal (required) due date:  24.9.19

Full application due date: 17.1.20